Intima-media thickness and endothelial dysfunction in GCK and HNF1A-MODY patients
Authors:
- Magdalena SzopaMSMagdalena Szopa
- Maciej T MaleckiMMMaciej T Malecki
- 1 March 2015
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 172 (3) , 277-283
Abstract
Objective: Mutations in the glucokinase (GCK) gene, along with hepatocyte nuclear factor 1A (HNF1A) gene mutations, are the most frequent cause of maturity-onset diabetes of the young (MODY). GCK-MODY patients are typically characterized by a moderate fasting hyperglycemia; however, little is known about atherosclerosis and intermediate-related phenotypes in these subjects.Design: To examine carotid artery intima-media thickness (IMT) and endothelial function assessed by brachial artery flow-mediated dilatation (FMD) in GCK gene mutations carriers and HNF1A-MODY.Methods: A total of 64 subjects with GCK gene mutations, and 52 HNF1A gene mutation carriers as well as 53 nondiabetic controls were examined. IMT and FMD were assessed by ultrasonography. Appropriate statistical tests were performed to assess differences between the groups, and multivariate linear regression was done for the association with IMT and FMD.Results: The clinical characteristics of all groups were similar with the mean age at examination of 35.1, 41.1, and 39.5 years for GCK, HNF1A and the control group respectively. The highest mean IMT value was in the HNF1A-MODY group: 7.0±1.4 mm, whereas it reached 6.3±1.4 mm in GCK mutation carriers and 6.3±1.3 mm in controls (P=0.008). After adjustment for possible clinical and biochemical cofounders, IMT remained higher in HNF1A-MODY patients as compared with GCK-MODY patients (P=0.02) and controls (P=0.0003). FMD was significantly lower in HNF1A (9.9±4.6%) and GCK-MODY (11.1±4.6%) patients in comparison with controls (13.9±4.7%; P=0.0001). After adjustment, FMD remained lower in HNF1A-MODY (P=0.0005) and GCK-MODY patients (P=0.01) as compared with controls.Conclusions: Both examined MODY groups demonstrated evidence of endothelial dysfunction. In addition, HNF1-MODY patients seem to be more prone to an early atherosclerotic phenotype.Keywords
This publication has 21 references indexed in Scilit:
- Circulating CD36 Is Reduced in HNF1A-MODY CarriersPLOS ONE, 2013
- Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetesEuropean Journal of Pharmacology, 2011
- Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A geneDiabetic Medicine, 2010
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- ISPAD Clinical Practice Consensus Guidelines 2006?2007 Definition, epidemiology and classificationPediatric Diabetes, 2006
- Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young AdultsCirculation, 2004
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJACC, 2002
- Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.Journal of Clinical Investigation, 1998
- Linkage of type 2 diabetes to the glucokinase geneThe Lancet, 1992
- Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitusNature, 1992